(TOUS) T. Rowe Price - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US87283Q8345 • Foreign Large Blend
TOUS: ETF, International Stocks, Large Cap, Developed Markets
T. Rowe Price Exchange-Traded Funds, Inc. (NYSE ARCA:TOUS) is an exchange-traded fund that focuses on investing in equity securities, with a significant emphasis on non-U.S. stocks, primarily in developed markets. The funds investment strategy is geared towards providing diversified exposure to international equities.
The funds asset allocation is characterized by a substantial commitment to non-U.S. stocks, which account for at least 65% of its net assets. This indicates a strong bias towards international equities, potentially offering investors a means to tap into growth opportunities outside the U.S. market. The funds investments are likely spread across various sectors and industries, providing a broad-based exposure to developed markets.
From a technical analysis perspective, TOUS has demonstrated a positive trend, with its current price of $30.37 exceeding its 20-day and 50-day simple moving averages (SMA) of $29.32 and $29.26, respectively. The funds 200-day SMA stands at $27.75, further indicating an overall upward trajectory. The average true range (ATR) of 0.56, or 1.86%, suggests moderate volatility. Given the current price being near its 52-week high of $30.62, the fund may be poised for a potential breakout or consolidation phase.
By combining technical and fundamental insights, a forecast for TOUS can be derived. The funds AUM of $619.99M USD indicates a reasonable level of investor interest. Considering the technical indicators, if the price maintains its position above the 20-day and 50-day SMAs, it may continue to trend upwards, potentially targeting the 52-week high. A break above this level could lead to further gains. Conversely, a decline below the 20-day SMA may signal a correction. Therefore, investors may want to monitor the funds price action relative to its SMAs and adjust their strategies accordingly.
Given the current market dynamics and the funds characteristics, a potential trading strategy could involve closely monitoring the funds price movements and adjusting positions based on breaks above or below key technical levels. Investors should also be aware of broader market trends and economic factors that could impact the funds performance.
Additional Sources for TOUS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TOUS ETF Overview
Market Cap in USD | 620m |
Category | Foreign Large Blend |
TER | 0.50% |
IPO / Inception | 2023-06-14 |
TOUS ETF Ratings
Growth Rating | 48.1 |
Fundamental | - |
Dividend Rating | 50.6 |
Rel. Strength | 0.82 |
Analysts | - |
Fair Price Momentum | 29.86 USD |
Fair Price DCF | - |
TOUS Dividends
Dividend Yield 12m | 2.71% |
Yield on Cost 5y | 3.22% |
Annual Growth 5y | 147.15% |
Payout Consistency | 66.7% |
TOUS Growth Ratios
Growth Correlation 3m | 39% |
Growth Correlation 12m | 51.8% |
Growth Correlation 5y | 88% |
CAGR 5y | 12.67% |
CAGR/Max DD 5y | 0.89 |
Sharpe Ratio 12m | 1.35 |
Alpha | 2.34 |
Beta | 0.727 |
Volatility | 13.29% |
Current Volume | 85.6k |
Average Volume 20d | 99.8k |
As of May 14, 2025, the stock is trading at USD 30.70 with a total of 85,561 shares traded.
Over the past week, the price has changed by +0.49%, over one month by +8.56%, over three months by +6.98% and over the past year by +13.73%.
Partly, yes. Based on ValueRay Analyses, T. Rowe Price (NYSE ARCA:TOUS) is currently (May 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 48.06 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TOUS as of May 2025 is 29.86. This means that TOUS is currently overvalued and has a potential downside of -2.74%.
T. Rowe Price has no consensus analysts rating.
According to ValueRays Forecast Model, TOUS T. Rowe Price will be worth about 34.1 in May 2026. The stock is currently trading at 30.70. This means that the stock has a potential upside of +11.17%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 34.1 | 11.2% |